A detailed history of Bellevue Group Ag transactions in Care Dx, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 3,145,456 shares of CDNA stock, worth $65.8 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares
3,145,456
Previous 3,912,575 19.61%
Holding current value
$65.8 Million
Previous $60.8 Million 61.62%
% of portfolio
1.65%
Previous 1.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.41 - $33.99 $11.1 Million - $26.1 Million
-767,119 Reduced 19.61%
3,145,456 $98.2 Million
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $162,018 - $346,110
-21,431 Reduced 0.54%
3,912,575 $60.8 Million
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $165,456 - $257,122
-20,786 Reduced 0.53%
3,934,006 $41.7 Million
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $68,570 - $179,962
13,994 Added 0.36%
3,954,792 $47.5 Million
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $1.57 Million - $2.53 Million
224,321 Added 6.04%
3,940,798 $27.6 Million
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $2.11 Million - $2.62 Million
277,386 Added 8.07%
3,716,477 $31.6 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $2.39 Million - $4.77 Million
270,643 Added 8.54%
3,439,091 $31.4 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $6.17 Million - $11.4 Million
567,002 Added 21.8%
3,168,448 $36.2 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $1.03 Million - $1.69 Million
63,922 Added 2.52%
2,601,446 $44.3 Million
Q2 2022

Aug 11, 2022

BUY
$20.49 - $39.72 $4.64 Million - $8.99 Million
226,348 Added 9.79%
2,537,524 $54.5 Million
Q1 2022

May 13, 2022

BUY
$28.19 - $46.6 $23.8 Million - $39.4 Million
844,624 Added 57.59%
2,311,176 $85.5 Million
Q4 2021

Feb 10, 2022

BUY
$41.2 - $73.6 $59.1 Million - $106 Million
1,435,609 Added 4639.53%
1,466,552 $66.7 Million
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $6.98 Million - $10.8 Million
-117,928 Reduced 79.21%
30,943 $1.96 Million
Q2 2021

Aug 12, 2021

SELL
$63.02 - $95.11 $2.62 Million - $3.95 Million
-41,500 Reduced 21.8%
148,871 $13.6 Million
Q1 2021

May 12, 2021

SELL
$57.62 - $95.6 $8.85 Million - $14.7 Million
-153,612 Reduced 44.66%
190,371 $13 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $32 Million - $59.5 Million
-771,920 Reduced 69.17%
343,983 $24.9 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $1.57 Million - $1.93 Million
-50,936 Reduced 4.37%
1,115,903 $42.3 Million
Q2 2020

Aug 13, 2020

SELL
$18.95 - $35.43 $2.09 Million - $3.9 Million
-110,212 Reduced 8.63%
1,166,839 $41.3 Million
Q1 2020

May 14, 2020

BUY
$13.94 - $28.25 $1.4 Million - $2.83 Million
100,321 Added 8.53%
1,277,051 $27.9 Million
Q4 2019

Feb 14, 2020

BUY
$19.24 - $28.41 $8.74 Million - $12.9 Million
454,075 Added 62.83%
1,176,730 $25.4 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $4.62 Million - $9.24 Million
230,647 Added 46.88%
722,655 $16.3 Million
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $1.56 Million - $2.4 Million
60,440 Added 14.0%
492,008 $17.7 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $2.32 Million - $4.11 Million
-104,920 Reduced 19.56%
431,568 $13.6 Million
Q4 2018

Feb 12, 2019

SELL
$19.89 - $30.02 $6.7 Million - $10.1 Million
-337,049 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$12.1 - $28.85 $4.08 Million - $9.72 Million
337,049 New
337,049 $9.72 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.12B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.